Dr. Ilias Karaiskos (Greece)
Dr. Ilias Karaiskos is an accomplished professional in the field of Internal Medicine and Infectious Diseases. He completed his Internal Medicine training in 2010 at the University Hospital Attikon in Athens, Greece, followed by a fellowship in Infectious Diseases at University Hospital Laikon, Athens, Greece. He achieved his PhD on the topic of ‘Pharmacokinetic of CMS and the application of a loading dose of CMS’, under the guidance of Professor Helen Giamarellou in 2014. His dedication in research were recognized with the Best PhD Award from the Hellenic Society, along with numerous awards in Greek congresses. He is currently employed as an Infectious Diseases at Hygeia General Hospital and is a member of the research group ‘the Critically Ill Study Group of ESCMID” and “ESCMID PK/PD of Anti-Infectives Study Group”. With a wealth of experience in critical care medicine, antimicrobial stewardship, and combating antimicrobial resistance, he possesses profound expertise in managing hospital and community-acquired infections, particularly focusing on multidrug resistance and prostatitis. Dr. Karaiskos stands out as a leader in the hospital and healthcare industry, demonstrating unparalleled skills and dedication to advancing infectious disease management.
Dr. Ilias Karaiskos is an accomplished professional in the field of Internal Medicine and Infectious Diseases. He completed his Internal Medicine training in 2010 at the University Hospital Attikon in Athens, Greece, followed by a fellowship in Infectious Diseases at University Hospital Laikon, Athens, Greece. He achieved his PhD on the topic of ‘Pharmacokinetic of CMS and the application of a loading dose of CMS’, under the guidance of Professor Helen Giamarellou in 2014. His dedication in research were recognized with the Best PhD Award from the Hellenic Society, along with numerous awards in Greek congresses. He is currently employed as an Infectious Diseases at Hygeia General Hospital and is a member of the research group ‘the Critically Ill Study Group of ESCMID” and “ESCMID PK/PD of Anti-Infectives Study Group”. With a wealth of experience in critical care medicine, antimicrobial stewardship, and combating antimicrobial resistance, he possesses profound expertise in managing hospital and community-acquired infections, particularly focusing on multidrug resistance and prostatitis. Dr. Karaiskos stands out as a leader in the hospital and healthcare industry, demonstrating unparalleled skills and dedication to advancing infectious disease management.